))
E96: The Story of Yuva Bio
Manage episode 388834547 series 3526088
Conteúdo fornecido por Venture In The South. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Venture In The South ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Anti-aging cosmeceuticals represent a competitive yet expansive market. When a new product emerges backed by compelling scientific evidence, it captures attention. Greg Schmergel, CEO of Yuva Bio, shares the narrative of entering the longevity market with a natural product demonstrating efficacy in enhancing cellular mitochondrial function in the skin and scalp, addressing hair loss in both men and women, and reducing skin wrinkling.
The active ingredient, Y100, was discovered through the screening of thousands of biologics using Yuva Bio's proprietary AI screening platform. Rigorous trials conducted by Contract Research Organizations affirmed the safety and effectiveness of the product. Yuva Bio has successfully launched its first product using a licensing model, following an oversubscribed seed equity round. The company has also secured contracts with three well-known brands for the introduction of new hair loss products in early 2024.
In our conversation, we explore Yuva's plans for launching additional products in the future, focusing on delivering extended longevity benefits.
Follow David on LinkedIn or reach out to David on Twitter/X @DGRollingSouth for comments.
Follow Paul on LinkedIn or reach out to Paul on Twitter/X @PalmettoAngel
We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.
142 episódios
Compartilhar
